- 13-8858-80 - Invitrogen Antibodies MET antibody

Submitted references Different growth and metastatic phenotypes associated with a cell-intrinsic change of Met in metastatic melanoma.

Adachi E, Sakai K, Nishiuchi T, Imamura R, Sato H, Matsumoto K
Oncotarget 2016 Oct 25;7(43):70779-70793

GM-CSF Mediates Mesenchymal-Epithelial Cross-talk in Pancreatic Cancer.

Waghray M, Yalamanchili M, Dziubinski M, Zeinali M, Erkkinen M, Yang H, Schradle KA, Urs S, Pasca Di Magliano M, Welling TH, Palmbos PL, Abel EV, Sahai V, Nagrath S, Wang L, Simeone DM
Cancer discovery 2016 Aug;6(8):886-99

Conditioned medium from umbilical cord mesenchymal stem cells induces migration and angiogenesis.

Shen C, Lie P, Miao T, Yu M, Lu Q, Feng T, Li J, Zu T, Liu X, Li H
Molecular medicine reports 2015 Jul;12(1):20-30

c-Met signaling promotes IL-6-induced myeloma cell proliferation.

Hov H, Tian E, Holien T, Holt RU, Våtsveen TK, Fagerli UM, Waage A, Børset M, Sundan A
European journal of haematology 2009 Apr;82(4):277-87

No comments: Submit comment

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Staining of human c-Met-transfected BAF/3 cells with 1.0 µg of Biotin Rat IgG1 Isotype Control (Product # 13-4301-82) (open histogram) or 1.0 µg of Anti-Human c-Met (HGF Receptor) Biotin (filled histogram) followed by Streptavidin PE (Product # 12-4317-87). Total viable cells were used for analysis.
Conjugate: Biotin

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: NULL
Conjugate: Biotin

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Figure 1 Synergistic effects between HGF and IL-6 in proliferation and migration of INA-6 cells. (A) INA-6 cells were grown in serum-free media with IL-6 and HGF as indicated for 3 d before estimation of DNA synthesis. Error bars represent SEM of triplicate measurements. * Denotes statistically significant difference from the IL-6 alone situation ( P < 0.05). (B) INA-6 cells were seeded in the top wells of transwell migration chambers. HGF was added to the bottom wells and IL-6 to both top and bottom wells. After 18 h, migration was determined as described in Materials and methods. Error bars represent SEM of duplicate measurements. #Denotes statistical significant difference between HGF with or without IL-6 was not reached ( P -value = 0.14). (C) INA-6 cells were grown in serum-free media with or without 100 ng/mL HGF or 1 ng/mL IL-6 over night, then harvested, lysed, and subjected to gel electrophoresis and Western blotting. The membrane was probed with an anti-c-Met antibody and a GAPDH antibody as loading control. (D) INA-6 cells were grown in serum-free media with or without 1 ng/mL IL-6 over night, labeled with FITC-conjugated antibody against c-Met or isotype control antibody and subjected to flow cytometry analysis. Upper panel - untreated cells labeled with FITC-c-Met antibody (bold line) compared with isotype control antibody (thin line); lower panel - c-Met expression in IL-6 treated cells (bold line) compared to untreated cells (thin line).
Conjugate: Biotin

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Figure 6 Clonal change in Met expression, gene expression profile, and tumor characteristics of Met-low and Met-high populations A. Representative histographical profiles defined as ""Met-low,"" ""Met-dim,"" or ""Met-high."" The threshold value for fluorescence intensity for Met expression was set at 300, and the cells were divided into 3 groups: ""Met-low,"" more than 85% of the total cells show a fluorescent intensity of less than 300; ""Met-high,"" more than 85% of the total cells show a fluorescent intensity of more than 300; and, ""Met-dim,"" intermediate cells between Met-low and Met-high. B. Change in Met expression during clonal expansion of B16-F10 and A2058 cells. Met-low and Met-high cells were sorted by flow cytometry, individually subjected to the clonal growth from a single cell, and cell-surface Met expression was analyzed in each population 21 days (B16-F10) or 28 days (A2058) later. Eleven (B16-F10) or twelve (A2058) clonal cell populations derived from Met-low and Met-high cells were analyzed. Met-low or Met-high clonal cells were obtained by independently performed cell sorting in twice. C. Comparison of gene expression profiles between Met-low, Met-high, and the Met-high cells transitted from Met-low (low-high). Among three samples in Met-low or Met-high, the data for two samples (lane 1 and 2) were taken from the same data sets used in Figure 2A and 3D . D. Tumor growth. Tumor growth by Met-low cells (n = 6) and the transitted Met-high cells (Met-low-Met-
Conjugate: Biotin

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Figure 4 Analysis of the extracellular expression levels of CXCR4, c-met and CCR2 in fibroblasts, HUVECs and UC-MSC using flow cytometry. The cells were detached using 0.25% trypsin and analyzed using PerCP/Cy5.5-labeled anti-human CCR2, PE-labeled anti-human CXCR4 and fluorescein isothio-cyanate-labeled anti-human c-met antibodies. Red lines represent antibody isotype controls, and black lines represent the expression of the indicated markers. CXCR4, C-X-C chemokine receptor 4; CCR2, C-C chemokine receptor 2; HUVECs, human umbilical vein endothelial cells; UC-MSCs, umbilical cord mesenchymal stem cells.
Conjugate: Biotin

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Figure 5 Migration of fibroblasts, HUVECs and UC-MSCs in response to UC-CM. (A) A total of 5x10 4 cells were collected and allowed to migrate. Lane 1, UC-CM; lane 2, DMEM; lanes 3-6, in the presence or absence of anti-SDF-1 (20 mu g/ml), anti-MCP-1 (20 mu g/ml) or anti-HGF (20 mu g/ml), respectively. Results are from a representative experiment and are expressed as the mean number of migrated cells in three random fields, scale bar=200 mu m. Cells that crossed the matrigel membrane were stained with crystal violet (magnification, x40). (B) Graphical presentation of the quantified data, presented as the number of migrated cells and expressed as the mean +- standard error of the mean. HUVECs, human umbilical vein endothelial cells; UC-MSCs, umbilical cord mesenchymal stem cells; UC-CM, UC-MSCs conditioned medium; DMEM, Dulbecco's modified Eagle's medium; SDF-1, stromal cell-derived factor 1; MCP-1, monocyte chemotactic protein 1; HGF, hepatocyte growth factor.
Conjugate: Biotin

13-8858-80

Antibody data